image
Healthcare - Biotechnology - NASDAQ - US
$ 0.035
-44.6 %
$ 119 K
Market Cap
0.01
P/E
BALANCE SHEET
10.1 M ASSETS
-48.10%
10.9 M LIABILITIES
-59.00%
-809 K EQUITY
88.69%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition TRACON Pharmaceuticals, Inc.
image
Current Assets 9.09 M
Cash & Short-Term Investments 8.56 M
Receivables 0
Other Current Assets 526 K
Non-Current Assets 1.02 M
Long-Term Investments 0
PP&E 942 K
Other Non-Current Assets 73 K
Current Liabilities 10.2 M
Accounts Payable 2.54 M
Short-Term Debt 236 K
Other Current Liabilities 7.4 M
Non-Current Liabilities 732 K
Long-Term Debt 732 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 8.6 17.4 24.1 32.1 16.4 25.1 29.5 35.7 41.4 35.0 2.3 2.5
Short Term Investments 0 0 0 4.0 0 14.0 5.0 8.7 10.8 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.5 0.8 1.7 1.6 1.7 3.0 3.2 2.5 2.3 1.5 99 K 0.1
Total Current Assets 9.1 18.2 24.9 36.9 17.3 40.6 36.1 45.6 53.3 35.7 2.4 2.6
PP&E 0.9 51 K 50 K 16 K 23 K 45 K 73 K 82 K 0.2 97 K 20 K 20 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 67 K 0.2 0 0 0 0 0 0 0 0 0
Other Long Term Assets 73 K 1.1 1.3 0.5 0.8 0 0 0 43 K 2.3 24 K 8 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 10.1 19.5 26.6 37.4 18.1 40.6 36.1 45.7 53.5 38.2 2.4 2.6
LIABILITIES
Accounts Payable 2.5 3.9 4.9 1.7 2.4 10.9 6.8 7.8 8.3 4.0 1.3 0.7
Short Term Debt 0.2 10.0 1.5 3.1 3.0 1.1 2.8 (7.5) 1.4 4.7 0.7 0
Other Current Liabilities 7.4 8.4 7.2 5.7 6.5 1.5 1.5 0.8 1.2 0.2 97 K 0
Total Current Liabilities 10.2 22.4 13.7 10.5 11.8 13.5 11.8 10.2 14.2 13.3 2.0 0.7
Long Term Debt 0.7 0 0 1.4 2.7 5.3 4.6 7.1 7.5 4.3 1.8 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0.4 0 0
Other Liabilities 0 4.2 0 0.4 0.8 0.4 0.4 21 K 0.9 50.3 24.0 19.6
Total Liabilities 10.9 26.6 14.8 12.4 15.4 19.2 19.1 17.4 22.5 70.3 27.8 20.3
EQUITY
Common Stock 44 K 23 K 19 K 15 K 4 K 30 K 18 K 16 K 12 K 2 K 2 K 2 K
Retained Earnings (240.5) (236.9) (207.8) (179.1) (162.3) (139.7) (104.7) (85.6) (58.6) (34.2) (27.4) (19.7)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 (0.1) 100 K (0.2) 82 K (0.1) 98 K 91 K
Total Equity (0.8) (7.2) 11.7 25.1 2.7 21.4 17.0 28.3 31.0 (32.2) (25.3) (17.7)
Total Liabilities and Equity 10.1 19.5 26.6 37.4 18.1 40.6 36.1 45.7 53.5 38.2 2.4 2.6
SHARES OUTSTANDING
Common Shares Outstanding 1.6 1.0 0.9 0.4 0.2 0.1 84 K 63.4 K 55.6 K 59.9 K 2.45 K 0.2